V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004697 | 300003261 | 1.75 | 90.4 | Adjuvant (A) | 2017-01-13 | 2017-02-12 | Gemcitabine + Capecitabine | N | N | 300024986 | CARBOPLATIN |
| 300004701 | 300003263 | 1.78 | 129.8 | null | 2016-06-28 | 2016-07-02 | DARS Trial | N | null | 300025007 | CISPLATIN + ETOPOSIDE |
| 300004702 | 300006180 | 1.6 | 90.8 | Curative (C) | 2016-09-28 | 2016-09-28 | ESPAC-4 TRIAL | N | N | 300025008 | FEC + DOCETAXEL |
| 300004703 | 300006180 | null | 67.9 | Adjuvant (A) | 2018-03-12 | 2018-03-27 | Capecitabine + Oxaliplatin 21day | 02 | N | 300025008 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004704 | 300006180 | 1.69 | 74.7 | Curative (C) | 2015-01-01 | 2015-01-01 | CARBOPLATIN + RT | 02 | N | 300025008 | CISPLATIN + VINORELBINE |
| 300004705 | 300006180 | 1.78 | 57.9 | Curative (C) | 2014-10-16 | 2014-11-13 | Carboplatin + Etoposide iv&po | Y | Y | 300025008 | CAPECITABINE + GEMCITABINE |
| 300004706 | 300003264 | 1.62 | 63.2 | Adjuvant (A) | 2015-08-13 | 2015-08-25 | FLUOROURACIL + MITOMYCIN | N | Y | 300025018 | FLUOROURACIL + MITOMYCIN + RT |
| 300004707 | 300003265 | null | 110.25 | Adjuvant (A) | 2015-03-20 | 2015-04-09 | Carboplatin AUC 6 - 10 | 2 | N | 300025029 | ESPAC TRIAL |
| 300004708 | 300003266 | null | 61.3 | Curative (C) | 2014-11-04 | 2014-11-14 | CISPLATIN + FLUOROURACIL + RT | N | N | 300025030 | PRICKLE TRIAL |
| 300004709 | 300003266 | 1.63 | 54 | Palliative (P) | 2017-03-25 | 2017-04-26 | Ipilimumab | 02 | N | 300025030 | CARBOPLATIN + ETOPOSIDE |
| 300004710 | 300003267 | 1.5 | null | Palliative (P) | 2016-12-14 | 2016-12-14 | Gemcitabine + Capecitabine | 02 | N | 300025038 | PEMBROLIZUMAB |
| 300004711 | 300003268 | 1.56 | 61.8 | Palliative (P) | 2018-01-20 | 2018-01-26 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 300025042 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004712 | 300003268 | 1.57 | 84 | Adjuvant (A) | 2015-09-09 | 2015-09-09 | ESPAC-4 TRIAL | N | null | 300025042 | CARBOPLATIN + RT |
| 300004713 | 300003269 | null | null | Curative (C) | 2015-04-02 | 2015-04-08 | Carboplatin AUC 6 - 10 | null | N | 300025059 | BEVACIZUMAB |
| 300004714 | 300003269 | null | 73.2 | Palliative (P) | 2014-01-17 | 2014-03-05 | GemCarbo Days 1+8 | N | null | 300025059 | CARBO + FLUOROURACIL |
| 300004715 | 300003270 | null | 93 | Palliative (P) | 2014-12-07 | 2014-12-07 | Folfirinox | 02 | N | 300025077 | PEMBROLIZUMAB |
| 300004716 | 300003271 | null | 87.1 | Neo-adjuvant (N) | 2013-07-11 | 2013-07-31 | Cisplatin + Docetaxel | Y | N | 300025079 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300004718 | 300006184 | null | 75.3 | Curative (C) | 2015-09-23 | 2015-09-30 | ESPAC-4 TRIAL | N | Y | 300025082 | CARBOPLATIN + RT |
| 300004719 | 300003273 | 1.66 | 66.8 | null | 2013-10-29 | 2013-11-29 | CARBOPLATIN + RT | N | null | 300025085 | CETUXIMAB + CISPLATIN + FU |
| 300004720 | 300003274 | 1.75 | 86 | Palliative (P) | 2016-10-03 | 2016-10-05 | Fluorouracil + Folinic Acid (Mayo) | N | N | 300025088 | ESPAC TRIAL |
| 300004721 | 300006185 | 1.55 | 80 | Curative (C) | 2014-01-07 | 2014-02-01 | FEC + TRASTUZUMAB | N | N | 300025091 | CISPLATIN + ETOPOSIDE |
| 300004722 | 300006185 | 0 | 48.4 | null | 2015-04-11 | 2015-04-20 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 300025091 | CISPLATIN + ETOPOSIDE |
| 300004723 | 300006185 | 1.69 | 119.2 | Curative (C) | 2013-07-28 | 2013-09-12 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | Y | 300025091 | CARBOPLATIN + RT |
| 300004724 | 300008218 | 1.63 | 0 | Curative (C) | 2014-07-04 | 2014-07-05 | ESPAC-4 TRIAL | 02 | N | 300025105 | CARBOPLATIN + RT |
| 300004725 | 300003275 | 1.79 | 85.6 | null | 2014-06-18 | 2014-06-18 | BCG Intravesical | N | N | 300025110 | CARBOPLATIN |
| 300004726 | 300003275 | null | 69.8 | Disease modification (D) | 2014-04-14 | 2014-05-12 | BENDAMUSTINE + RITUXIMAB | N | N | 300025110 | FLUOROURACIL + MITOMYCIN + RT |
| 300004729 | 300003277 | 1.58 | 95 | Not known (9) | 2012-08-06 | 2012-08-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | 300025136 | FLUOROURACIL |
| 300004730 | 300003277 | 1.63 | 50.3 | Adjuvant (A) | null | 2016-05-25 | CARBOPLATIN + RT | N | N | 300025136 | TEMOZOLOMIDE |
| 300004731 | 300003278 | 1.61 | 60 | Neo-adjuvant (N) | 2015-10-03 | 2015-11-09 | Cisplatin + Etoposide (3 day) | N | N | 300025156 | FEC + TRASTUZUMAB |
| 300004732 | 300003279 | 1.54 | 0 | Curative (C) | 2013-06-29 | 2013-07-07 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 300025157 | FLUOROURACIL + MITOMYCIN + RT |
| 300004733 | 300003279 | 1.52 | 60.4 | Palliative (P) | 2013-02-06 | 2013-02-07 | Carboplatin AUC 2 - 5 | 02 | N | 300025157 | PEMBROLIZUMAB |
| 300004734 | 300003280 | 1.62 | 45.5 | Adjuvant (A) | 2017-02-10 | 2017-02-10 | Mitotane 2g | N | Y | 300025162 | BCG |
| 300004735 | 300003281 | 1.56 | 85.9 | null | 2017-02-28 | 2017-02-28 | ECX | 02 | null | 300025174 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300004736 | 300003281 | 1.5 | 60.3 | Adjuvant (A) | 2017-05-14 | 2017-05-21 | Carboplatin AUC 2 - 5 | 02 | N | 300025174 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004737 | 300003282 | null | 63.8 | Curative (C) | 2013-07-05 | 2013-07-05 | CARBOPLATIN + RT | N | null | 300025182 | PEMBROLIZUMAB |
| 300004738 | 300003283 | null | null | Curative (C) | 2014-06-09 | 2014-06-13 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 300025189 | AFATINIB |
| 300004739 | 300006191 | 1.84 | 57.7 | Curative (C) | 2014-06-17 | 2014-07-12 | CTD Attenuated (Thalidomide 50mg) | Y | Y | 300025196 | BCG |
| 300004740 | 300003284 | 1.76 | 0 | null | 2016-03-25 | 2016-03-25 | Capecitabine 35days + RT | 02 | null | 300025197 | CARBOPLATIN + RT |
| 300004741 | 300003284 | 1.68 | 63.4 | Adjuvant (A) | 2017-03-25 | 2017-03-25 | BCG Intravesical | N | N | 300025197 | FLUOROURACIL |
| 300004742 | 300003284 | 1.82 | 66.6 | Palliative (P) | 2015-01-24 | 2015-02-07 | Carboplatin + Etoposide IV 3 day | N | Y | 300025197 | CARBO + FLUOROURACIL |
| 300004743 | 300003285 | 1.74 | null | Palliative (P) | 2015-12-30 | 2015-12-31 | FLUOROURACIL + MITOMYCIN + RT | 01 | N | 300025214 | CAPECITABINE + CISPLATIN + RT |
| 300004744 | 300003286 | 1.73 | 81.1 | Curative (C) | 2016-05-13 | 2016-05-15 | CARBOPLATIN + RT | N | null | 300025219 | COMPARE TRIAL |
| 300004745 | 300006193 | 1.64 | null | null | 2016-11-29 | 2016-12-09 | Capecitabine + Oxaliplatin 14day | N | N | 300025221 | PACLITAXEL |
| 300004748 | 300007496 | 1.78 | 75.5 | Disease modification (D) | 2016-12-30 | 2017-01-10 | FLUOROURACIL | 02 | N | 300025227 | CARBOPLATIN + RT |
| 300004749 | 300003288 | 1.72 | 51 | Palliative (P) | 2017-06-29 | 2017-06-30 | Carboplatin + Etoposide iv&po | 02 | null | 300025228 | DACARBAZINE |
| 300004750 | 300003288 | 1.59 | 84.7 | Palliative (P) | 2017-07-30 | 2017-08-03 | Carboplatin + Etoposide iv&po | N | N | 300025228 | CARBOPLATIN |
| 300004751 | 300003289 | 1.79 | 87 | Adjuvant (A) | 2013-11-07 | 2013-11-09 | Carbo F | N | N | 300025236 | CARBOPLATIN + ETOPOSIDE |
| 300004752 | 300003289 | 1.59 | 88.3 | null | 2016-09-08 | 2016-09-08 | BENDAMUSTINE + RITUXIMAB | 02 | N | 300025236 | CAPECITABINE + OXALIPLATIN |
| 300004753 | 300003290 | 1.55 | 89 | Neo-adjuvant (N) | 2015-04-30 | 2015-05-07 | Folfirinox | N | N | 300025245 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 300004754 | 300003290 | 1.73 | 74.8 | Curative (C) | 2014-06-02 | 2014-06-13 | Carboplatin AUC 2 - 5 | 01 | N | 300025245 | MITOMYCIN INTRAVESICULAR |